1. 2. 3. 83.
ISI PubMed Article
Crazzolara, R. et al. Potentiating effects of RAD001 (Everolimus) on vincristine therapy in childhood acute
lymphoblastic leukemia. Blood 113, 3297–3306 (2009).
0. 1. 84.
PubMed Article
Takeuchi, H. et al. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by
phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res. 65, 3336–3346 (2005).
0. 1. 2. 85.
CAS ISI PubMed
Carayol, N. et al. Critical roles for mTORC2- and rapamycin-insensitive mTORC1-complexes in growth and
survival of BCR-ABL-expressing leukemic cells. Proc. Natl. Acad. Sci. USA 107, 12469–12474 (2010).
0. 1. 2. 86. 0. 1. 2. 3. 87.
ADS PubMed Article
Ertmer, A. et al. The anticancer drug imatinib induces cellular autophagy. Leukemia 21, 936–942 (2007).
CAS ISI PubMed Article
Milano, V., Piao, Y., LaFortune, T. & de Groot, J. Dasatinib-induced autophagy is enhanced in combination
with temozolomide in glioma. Mol. Cancer Ther. 8, 394–406 (2009).
0. 1. 2. 3. 88.
CAS ISI PubMed Article
Gorzalczany, Y. et al. Combining an EGFR directed tyrosine kinase inhibitor with autophagy-inducing drugs:
a beneficial strategy to combat non-small cell lung cancer. Cancer Lett. 310, 207–215 (2011).
0. 1. 2. 89.
CAS PubMed Article
Ding, W.X. et al. Oncogenic transformation confers a selective susceptibility to the combined suppression of
the proteasome and autophagy. Mol. Cancer Ther. 8, 2036–2045 (2009).
0. 1. 2. 3. 90.
CAS ISI PubMed Article
Zhu, K., Dunner, K. Jr. & McConkey, D.J. Proteasome inhibitors activate autophagy as a cytoprotective
response in human prostate cancer cells. Oncogene 29, 451–462 (2010).
0. 1. 2. 3. 91.
CAS ISI PubMed Article
Shao, Y., Gao, Z., Marks, P.A. & Jiang, X. Apoptotic and autophagic cell death induced by histone
deacetylase inhibitors. Proc. Natl. Acad. Sci. USA 101, 18030–18035 (2004).
0. 1. 2. 92.
CAS PubMed Article
Carew, J.S. et al. Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor
SAHA to overcome Bcr-Abl-mediated drug resistance. Blood 110, 313–322 (2007).
0. 1. 2. 3. 93.
CAS ISI PubMed Article
Ellis, L. et al. The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor
signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy. Blood 114, 380–393 (2009).
0. 1.
CAS ISI
2. 3. 94.
PubMed Article
Kanzawa, T. et al. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell
Death Differ. 11, 448–457 (2004).
0. 1. 2. 3. 95.
CAS ISI PubMed Article
Martin, A.P. et al. BCL-2 family inhibitors enhance histone deacetylase inhibitor and sorafenib lethality via
autophagy and overcome blockade of the extrinsic pathway to facilitate killing. Mol. Pharmacol. 76, 327–341 (2009).
0. 1. 2. 3. 96.
CAS ISI PubMed Article
Wei, Y. et al. The combination of a histone deacetylase inhibitor with the Bcl-2 homology domain-3 mimetic
GX15–070 has synergistic antileukemia activity by activating both apoptosis and autophagy. Clin. Cancer Res. 16, 3923–3932 (2010).
0. 1. 2. 3. 97.
CAS ISI PubMed Article
Qian, W., Liu, J., Jin, J., Ni, W. & Xu, W. Arsenic trioxide induces not only apoptosis but also autophagic cell
death in leukemia cell lines via up-regulation of Beclin-1. Leuk. Res. 31, 329–339 (2007).
0. 1. 2. 3. 98.
CAS ISI PubMed Article
Kanzawa, T., Kondo, Y., Ito, H., Kondo, S. & Germano, I. Induction of autophagic cell death in malignant
glioma cells by arsenic trioxide. Cancer Res. 63, 2103–2108 (2003).
0. CAS
1. 2. 99.
ISI PubMed
Opipari, A.W. Jr. et al. Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res. 64,
696–703 (2004).
0. 1. 2. 3. 100.
CAS ISI PubMed Article
Seglen, P.O. & Gordon, P.B. 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation
in isolated rat hepatocytes. Proc. Natl. Acad. Sci. USA 79, 1889–1892 (1982). 0. 1. 2. 101. 0. 1. 2. 3. 102.
CAS PubMed Article
Boya, P. et al. Inhibition of macroautophagy triggers apoptosis. Mol. Cell. Biol. 25, 1025–1040 (2005).
CAS ISI PubMed Article
Blommaart, E.F., Krause, U., Schellens, J.P., Vreeling-Sindelarova, H. & Meijer, A.J. The
phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur. J. Biochem. 243, 240–246 (1997). 0. 1. 2. 3. 103.
CAS ISI PubMed Article
Petiot, A., Ogier-Denis, E., Blommaart, E.F., Meijer, A.J. & Codogno, P. Distinct classes of
phosphatidylinositol 3′-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J. Biol. Chem. 275, 992–998 (2000). 0. 1.
CAS ISI
